Clinical Research Directory
Browse clinical research sites, groups, and studies.
Phase IIT Trial of SNA009
Sponsor: SmartNuclide Biopharma
Summary
This clinical trial is a single-center, open-label, dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics and radiation dosimetry of 68Ga-NODAGA-SNA009 in patients with colorectal cancer.
Official title: A Clinical Study Evaluating the Safety, Tolerability, Biodistribution and Radiation Dose Measurement of 68Ga-NODAGA-SNA009 in Patients With Colorectal Cancer
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2025-10-30
Completion Date
2025-12-31
Last Updated
2026-05-19
Healthy Volunteers
No
Conditions
Interventions
68Ga-NODAGA-SNA009
68Ga-NODAGA-SNA009 is a radiopharmaceutical agents that targets GPA33
Locations (1)
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, China